TAM
SLXP

Tocqueville Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Tocqueville Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-77,595
Closed -$13.4M – 1038
2015
Q1 		$13.4M Sell
77,595
-39,497
-34% -$5.8M 0.16% 167
2014
Q4 		$13.5M Buy
117,092
+34,725
+42% +$4.21M 0.14% 175
2014
Q3 		$12.9M Buy
82,367
+1,434
+2% +$208K 0.14% 176
2014
Q2 		$9.98M Sell
80,933
-1,997
-2% -$221K 0.1% 219
2014
Q1 		$8.59M Buy
82,930
+4,520
+6% +$463K 0.11% 186
2013
Q4 		$7.05M Buy
78,410
+8,549
+12% +$682K 0.09% 208
2013
Q3 		$4.67M Sell
69,861
-3,881
-5% -$267K 0.06% 309
2013
Q2 		$4.88M Buy
+73,742
New +$4.22M 0.07% 286

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Tocqueville Asset Management's SLXP Position: Q2 2015 in Review

Tocqueville Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 77,595 shares — an estimated $13.4M sold.

Tocqueville Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $13.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Tocqueville Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 77,595 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $13.4M.
  • Tocqueville Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Tocqueville Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $13.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Tocqueville Asset Management's 13F filing for Q2 2015, filed 31 Jul 2015.